Liu et al. [15] found that SYPL1 was upregulated in colon cancer tissue and that serum SYPL1 levels were significantly higher in patients with CRC than in patients with adenoma and intact patients (AUC: 0.94 sensitivity: 86%, specificity: 91%). This evidence concerns the gene SYPL1 and colorectal carcinoma.